179 related articles for article (PubMed ID: 36938744)
1. Is baclofen the least worst option for spasticity management in children?
Brandenburg JE
J Pediatr Rehabil Med; 2023; 16(1):11-17. PubMed ID: 36938744
[TBL] [Abstract][Full Text] [Related]
2. New approaches to managing spasticity in children with cerebral palsy.
Im D; McDonald CM
West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
[No Abstract] [Full Text] [Related]
3. The use of botulinum toxin and intrathecal baclofen in hip dysplasia in cerebral palsy.
Gormley M
Dev Med Child Neurol; 2023 Aug; 65(8):1125. PubMed ID: 37208907
[No Abstract] [Full Text] [Related]
4. Intrathecal baclofen therapy in children with cerebral palsy.
Brown TR
Arch Phys Med Rehabil; 2003 Apr; 84(4):624; author reply 624. PubMed ID: 12690609
[No Abstract] [Full Text] [Related]
5. Pharmacologic management of spasticity in cerebral palsy.
Mooney JF; Koman LA; Smith BP
J Pediatr Orthop; 2003; 23(5):679-86. PubMed ID: 12960637
[No Abstract] [Full Text] [Related]
6. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Baker KW; Tann B; Mutlu A; Gaebler-Spira D
J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.
Kraus T; Gegenleitner K; Svehlik M; Novak M; Steinwender G; Singer G
Eur J Paediatr Neurol; 2017 May; 21(3):565-569. PubMed ID: 28237420
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic interventions for reducing spasticity in cerebral palsy.
Patel DR; Soyode O
Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal baclofen therapy does not prevent hip displacement in children with cerebral palsy.
Howard JJ; Shrader MW
Dev Med Child Neurol; 2023 Aug; 65(8):1124. PubMed ID: 37208917
[No Abstract] [Full Text] [Related]
10. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin.
Sgouros S; Seri S
Pediatr Neurosurg; 2002 Nov; 37(5):225-30. PubMed ID: 12411712
[TBL] [Abstract][Full Text] [Related]
11. Clinical practices in intrathecal baclofen pump implantation in children with cerebral palsy in France.
Mietton C; Nuti C; Dohin B; Bayle B; Fernandez B; Poirot I; Gautheron V; Vuillerot C
Ann Phys Rehabil Med; 2016 Sep; 59(4):282-4. PubMed ID: 27158102
[No Abstract] [Full Text] [Related]
12. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel.
Butler C; Campbell S
Dev Med Child Neurol; 2000 Sep; 42(9):634-45. PubMed ID: 11034458
[No Abstract] [Full Text] [Related]
13. Benefit of enteral baclofen in the management of spasticity in cerebral palsy.
Srinivasan R
J Pediatr Rehabil Med; 2023; 16(1):19-24. PubMed ID: 36938745
[No Abstract] [Full Text] [Related]
14. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of spasticity].
Autti-Rämö I
Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
[No Abstract] [Full Text] [Related]
16. [Management of spasticity in children with cerebral palsy].
Matthews DJ; Balaban B
Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
[TBL] [Abstract][Full Text] [Related]
17. [Intrathecal baclofen therapy. Overdose during replacement of a medication pump].
Kramer K; Weber M; Koulousakis A; Lier H; Krep H
Anaesthesist; 2009 Sep; 58(9):891-6. PubMed ID: 19730795
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen therapy and the child with cerebral palsy.
Vitztum C; Olney B
Orthop Nurs; 2000; 19(1):43-8. PubMed ID: 11062623
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal baclofen in the management of spasticity due to cerebral palsy.
Vloeberghs M; Keetley R; Morton R
Pediatr Rehabil; 2005; 8(3):172-9. PubMed ID: 16087551
[TBL] [Abstract][Full Text] [Related]
20. Patient management of cerebral origin spasticity with intrathecal baclofen.
Rawlins P
J Neurosci Nurs; 1998 Feb; 30(1):32-5, 40-6. PubMed ID: 9604821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
